Liquidity, Capital Resources and Going Concern
On January 20, 2021, the Company consummated the Public Offering of 23,000,000 Units, which includes the full exercise by underwriter of its over-allotment option in the amount of 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $230,000,000. Simultaneously with the closing of the Public Offering, the Company consummated the sale of 2,840,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $4,260,000.
Following the Public Offering, the full exercise of the over-allotment option, and the sale of the Private Placement Warrants, a total of $230,000,000 was placed in the Trust Account. We incurred $13,156,274 in transaction costs, including $2,760,000 of underwriting fees, net of reimbursement, $9,890,000 of deferred underwriting fees and $506,274 of other offering costs.
For the nine months ended September 30, 2022, net cash used by operating activities was approximately $0.66 million. Net income of approximately $5.2 million was affected by noncash items such as the change in fair value of the warrant liabilities of approximately $4.9 million, change in fair value of convertible promissory notes of approximately $0.6 million, and interest earned on marketable securities held in trust account of approximately $1.3 million. Changes in operating assets and liabilities provided approximately $0.98 million of cash from operating activities.
For the nine months ended September 30, 2021, net cash provided by operating activities was approximately $2.2 million. Net income of $5.2 million was affected by noncash items such as the change in fair value of the warrant liability of $7.2 million, change in fair value of convertible promissory notes of $0.13 million, interest earned on marketable securities held in trust account of $16 thousand and transaction costs associated with the Initial Public Offering of $0.6 million. Changes in operating assets and liabilities used $0.7 million of cash from operating activities.
At September 30, 2022, we had cash held in the Trust Account of $231,349,593. We are using substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (less deferred underwriting commissions and income taxes payable), to complete our business combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
At September 30, 2022, we had cash of $69,053 held outside of the Trust Account. We are using the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants of the post-Business Combination entity, at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants.
As of September 30, 2022, the Company had approximately $69,000 in cash and working capital deficit of approximately $3,628,450 (not taking into account franchise and income tax obligations of $583,085 that may be paid using investment income earned in the Trust Account).
In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements-Going Concern,” management has evaluated the Company’s liquidity and financial condition and determined that it may not be sufficient to meet the Company’s obligation over the period of twelve months from the issuance date of the financial statements. The Company’s sponsor has agreed to provide support to enable the Company to continue its operations and meet its potential obligations over a period of one year from the issuance date of these financial statements.